Tan Aik Na 4
4 · Wave Life Sciences Ltd. · Filed Aug 19, 2025
Insider Transaction Report
Form 4
Tan Aik Na
Director
Transactions
- Sale
Ordinary Shares
2025-08-15$9.25/sh−21,000$194,250→ 40,388 total - Exercise/Conversion
Ordinary Shares
2025-08-15$9.13/sh+21,000$191,730→ 61,388 total - Exercise/Conversion
Share Option (right to buy)
2025-08-15−21,000→ 0 totalExercise: $9.13Exp: 2025-08-18→ Ordinary Shares (21,000 underlying)
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
- [F2]These share options are fully vested.